Dana Insulin Pump

Meters & Monitors

Blood Glucose Meters Next Current Continuous Monitors Next Comparison of Available Monitors Next Various Future Monitors Next Improving Today's Meters Next Other Monitors Next Older Monitors

Future Monitoring

AiMedics Next A.Menarini Diagnostics Next Cybiocare OHD Next InLight Solutions Next Integrated Applications Next Kumetrix Next LighTouch Medical Next Optiscan Next Orsense Next Oxygen Biotherapeutics Next Sensors For Medicine and Science Next Sensys Medical Next Sentek Next Solianis Next Sontra Next SpectRx Next Visual Pathways

Key
Non-Invasive Non-Invasive
Semi-Invasive Semi-Invasive
Surgical Surgical
Continuous Continuous

InLight Solutions - Near Infrared Technology Non-Invasive

InLight Solutions researches and develops sensor-based measurement systems for life science applications. They have ties with researchers at the University of New Mexico, and has been working on a Near-IR device for several years. InLight's optics and software design is specific to distinguish the target molecule glucose, from similar molecules like water.

Their devices consist of three parts: a light source, an optical detector, and a spectrometer. The light shines into the skin and a small amount of that light reflects back. The reflected light is analyzed by the spectrometer with subsequent measurement by the detector. Measuring the differences between the light that went into the skin with the light that the detector collects. Each molecule's response to the light can be distinguished by different vibration characteristics, thus the system can be programmed to analyze a particular molecule. This system is optimized to give an accurate quantitative measurement of glucose concentrations in the body.

Veralight's Scout DS

VeraLight, Inc. was established in 2004 as a spinout of Inlight Solutions to focus on a comprehensive approach to noninvasive diabetes screening. They are developing the Scout DS instrument for screening of type 2 and pre-diabetes. Scout DS employs fluorescence spectroscopy to noninvasively measure advanced glycation endproducts (AGEs) in the skin of a subject's forearm. Skin AGEs are a well-known biomarker of diabetes, an excellent indicator of cumulative hyperglycemic exposure, and have been shown to predict the development of type 2 diabetes.

You can follow the latest news from VeraLight at their website.